Strategies for selection of antibodies by phage display

Current Opinion in Biotechnology

Volumn 9, Issue 1, 1998, Pages 102-108

  Griffiths, Andrew D ^a   Duncan, Alexander R ^b  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

^b MEDIMMUNE LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY;

ANTIBODY AFFINITY; PHAGE DISPLAY; PRIORITY JOURNAL; REVIEW;

EID: 0031933840     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(98)80092-X     Document Type: Article

References (64)

1. Smith GP. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science. 228:1985;1315-1317.
2. McCafferty J, Griffiths AD, Winter G, Chiswell DJ. Phage antibodies: filamentous phage displaying antibody variable domains. Nature. 348:1990;552-554.
3. Winter G, Griffiths AD, Hawkins RE, Hoogenboom HR. Making antibodies by phage display technology. Annu Rev Immunol. 12:1994;433-455.
4. Hoogenboom HR. Designing and optimizing library selection strategies for generating high-affinity antibodies. Trends Biotechnol. 15:1997;62-70.
5. Hoogenboom HR, Griffiths AD, Johnson KS, Chiswell DJ, Hudson P, Winter G. Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. Nucleic Acids Res. 19:1991;4133-4137.
6. Breitling F, Dübel S, Seehaus T, Klewinghaus I, Little M. A surface expression vector for antibody screening. Gene. 104:1991;147-153.
7. Garrard LJ, Yang M, O'Connell MP, Kelley RF, Henner DJ. Fab assembly and enrichment in a monovalent phage display system. Bio/technology. 9:1991;1373-1377.
8. Barbas CF, Kang AS, Lerner RA, Benkovic SJ. Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc Natl Acad Sci USA. 88:1991;7978-7982.
9. Chang CN, Landolfi NF, Queen C. Expression of antibody Fab domains on bacteriophage surfaces. J Immunol. 147:1991;3610-3614.
10. Kang AS, Barbas CF, Janda KD, Benkovic SJ, Lerner RA. Linkage of recognition and replication functions by assembling combinatorial antibody Fab libraries along phage surfaces. Proc Natl Acad Sci USA. 88:1991;4363-4366.
11. Vieira J, Messing J. Production of single-stranded plasmid DNA. Methods Enzymol. 153:1987;3-11.
12. Griffiths AD, Malmqvist M, Marks JD, Bye JM, Embleton MJ, McCafferty J, Baier M, Holliger KP, Gorick BD, Hughes-Jones NC, et al. Human anti-self antibodies with high specificity from phage display libraries. EMBO J. 12:1993;725-734.
13. Rakonjac J, Jovanovic G, Model P. Filamentous phage infection-mediated gene expression: construction and propagation of the gIII deletion mutant helper phage R408d3. Gene. 198:1997;99-103.
14. Holliger P, Prospero T, Winter G. 'Diabodies': small bivalent and bispecific antibody fragments. Proc Natl Acad Sci USA. 90:1993;6444-6448.
15. Perisic O, Webb PA, Holliger P, Winter G, Williams RL. Crystal structure of a diabody, a bivalent antibody fragment. Structure. 2:1994;1217-1226.
16. Pei XY, Holliger P, Murzin AG, Williams RL. The 2.0-Å resolution crystal structure of a trimeric antibody fragment with noncognate VH-VL domain pairs shows a rearrangement of VH CDR3. Proc Natl Acad Sci USA. 94:1997;9637-9642.
17. Iliades P, Kortt AA, Hudson PJ. Triabodies: single chain Fv fragments without a linker form trivalent trimers. FEBS Lett. 409:1997;437-441.
18. Holliger P, Brissinck J, Williams RL, Thielemans K, Winter G. Specific killing of lymphoma cells by cytotoxic T-cells mediated by a bispecific diabody. Protein Eng. 9:1996;299-305.
19. Holliger P, Wing M, Pound JD, Bohlen H, Winter G. Retargeting serum immunoglobulin with bispecific diabodies. Nat Biotechnol. 15:1997;632-636.
20. Kontermann RE, Wing MG, Winter G. Complement recruitment using bispecific diabodies. Nat Biotechnol. 15:1997;629-631.
21. Zhu Z, Presta LG, Zapata G, Carter P. Remodeling domain interfaces to enhance heterodimer formation. Protein Sci. 6:1997;781-788.
22. McGuinness BT, Walter G, Fitzgerald K, Schuler P, Mahoney W, Duncan AR, Hoogenboom HR. Phage diabody repertoires for selection of large numbers of bispecific antibody fragments. Nat Biotechnol. 14:1996;1149-1154.
23. Clackson T, Hoogenboom HR, Griffiths AD, Winter G. Making antibody fragments using phage display libraries. Nature. 352:1991;624-628.
24. Burton DR, Barbas C III, Persson M, Koenig S, Chanock RM, Lerner RA. A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proc Natl Acad Sci USA. 88:1991;10134-10137.
25. Marks JD, Hoogenboom HR, Bonnert TP, McCafferty J, Griffiths AD, Winter G. By-passing immunization: human antibodies from V-gene libraries displayed on phage. J Mol Biol. 222:1991;581-597.
26. Tomlinson IM. Immunoglobulin genes. Delves PJ, Roitt I. 2 Encyclopedia of Immunology. 1998;Academic Press, London.
27. Barbas C III, Burton DR. Selection and evolution of high-affinity human anti-viral antibodies. Trends Biotechnol. 14:1996;230-234.
28. Ohlin M, Borrebaeck CA. Characteristics of human antibody repertoires following active immune responses in vivo. Mol Immunol. 33:1996;583-592.
29. Pereira S, Van BP, Elder D, Maruyama H, Jacob L, Sivanandham M, Wallack M, Siegel D, Herlyn D. Combinatorial antibodies against human malignant melanoma. Hybridoma. 16:1997;11-16.
30. Graus YF, de Baets MH, Parren PW, Berrih AS, Wokke J, van Breda Vriesman PJ, Burton DR. Human anti-nicotinic acetylcholine receptor recombinant Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodies. J Immunol. 158:1997;1919-1929.
31. Finnern R, Pedrollo E, Fisch I, Wieslander J, Marks JD, Lockwood CM, Ouwehand WH. Human autoimmune antiproteinase 3 scFv from a phage display library. Clin Exp Immunol. 107:1997;269-281.
32. Roben P, Barbas SM, Sandoval L, Lecerf JM, Stollar BD, Solomon A, Silverman GJ. Repertoire cloning of lupus anti-DNA autoantibodies. J Clin Invest. 98:1996;2827-2837.
33. Lang IM, Barbas C III, Schleef RR. Recombinant rabbit Fab with binding activity to type-1 plasminogen activator inhibitor derived from a phage-display library against human alpha-granules. Gene. 172:1996;295-298.
34. Davies EL, Smith JS, Birkett CR, Manser JM, Anderson DD, Young JR. Selection of specific phage-display antibodies using libraries derived from chicken immunoglobulin genes. J Immunol Methods. 186:1995;125-135.
35. Yamanaka HI, Inoue T, Ikeda TO. Chicken monoclonal antibody isolated by a phage display system. J Immunol. 157:1996;1156-1162.
36. 10 clone) naive scFv phage library is constructed from V-genes of 43 non-immunised human donors and used to rapidly recover nanomolar and sub-nanomolar affinity antibodies to multiple haptens and protein antigens.
37. Griffiths AD, Williams SC, Hartley O, Tomlinson IM, Waterhouse P, Crosby WL, Kontermann RE, Jones PT, Low NM, Allison TJ, et al. Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J. 13:1994;3245-3260.
38. Hoogenboom HR, Winter G. By-passing immunisation: human antibodies from synthetic repertoires of germline VH gene segments rearranged in vitro. J Mol Biol. 227:1992;381-388.
39. Nissim A, Hoogenboom HR, Tomlinson IM, Flynn G, Midgley C, Lane D, Winter G. Antibody fragments from a 'single pot' phage display library as immunochemical reagents. EMBO J. 13:1994;692-698.
40. de Kruif J, Boel E, Logtenberg T. Selection and application of human single chain Fv antibody fragments from a semi-synthetic phage antibody display library with designed CDR3 regions. J Mol Biol. 248:1995;97-105.
41. de Kruif J, Terstappen L, Boel E, Logtenberg T. Rapid selection of cell subpopulation-specific human monoclonal antibodies from a synthetic phage antibody library. Proc Natl Acad Sci USA. 92:1995;3938-3942.
42. Van Ewijk W, de Kruif J, Germeraad WT, Berendes P, Ropke C, Platenburg PP, Logtenberg T. Subtractive isolation of phage-displayed single-chain antibodies to thymic stromal cells by using intact thymic fragments. Proc Natl Acad Sci USA. 94:1997;3903-3908.
43. de Wildt R, Finnern R, Ouwehand WH, Griffiths AD, van Venrooij W, Hoet RM. Characterization of human variable domain antibody fragments against the U1 RNA-associated A protein, selected from a synthetic and patient-derived combinatorial V gene library. Eur J Immunol. 26:1996;629-639.
44. de Lalla C, Tamborini E, Longhi R, Tresoldi E, Manoni M, Siccardi AG, Arosio P, Sidoli A. Human recombinant antibody fragments specific for a rye-grass pollen allergen: characterization and potential applications. Mol Immunol. 33:1996;1049-1058.
45. Doorbar J, Foo C, Colman N, Medcalf L, Hartley O, Prospero T, Napthiene S, Stirling J, Winter G, Griffin H. Characterization of events during the late stages of HPV 16 infection in vivo using high-affinity synthetic Fabs to E4. of special interest Virology. 238:1997;40-52 An interesting example of a high affinity (1.0 nM) Fab, isolated directly from a synthetic phage antibody library, being used in basic research; in this case to characterise events in papillomavirus infection.
46. Xie M-H, Yuan J, Adams C, Gurney A. Direct demonstration of MuSK involvement in acetycholine receptor clustering through identification of agonist ScFv. of outstanding interest Nat Biotechnol. 15:1997;768-771 A titilating example of how antibodies with agonist activity can be derived by phage display. Potentially, agonists can yield much information about receptor biology. In this case the antibodies with receptor agonist activity (against MuSK) are selected directly from a large naive library.
47. D.
48. Yang WP, Green K, Pinz SS, Briones AT, Burton DR, Barbas C III. CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range. J Mol Biol. 254:1995;392-403.
49. Osbourn JK, Field A, Wilton J, Derbyshire F, Earnshaw JC, Jones PT, Allen D, McCafferty J. Generation of a panel of related human scFv antibodies with high affinities for human CEA. Immunotechnology. 2:1996;181-196.
50. Barbas CF, Hu D, Dunlop N, Sawyer L, Cababa D, Hendry RM, Nara PL, Burton DR. In vitro evolution of a neutralizing human antibody to human immunodeficiency virus type 1 to enhance affinity and broaden strain cross-reactivity. Proc Natl Acad Sci USA. 91:1994;3809-3813.
51. Tomlinson IM, Walter G, Jones PT, Dear PH, Sonnhammer EL, Winter G. The imprint of somatic hypermutation on the repertoire of human germline V genes. of special interest J Mol Biol. 256:1996;813-817 A comprehensive study of the human antibody response showing that initially diversity is focused at the centre of the binding site, but somatic hypermutation spreads diversity to regions at the periphery of the binding site that are highly conserved in the primary repertoire.
52. Ignatovich O, Tomlinson IM, Jones PT, Winter G. The creation of diversity in the human immunoglobulin V(lambda) repertoire. J Mol Biol. 268:1997;69-77.
53. Clackson T, Wells JA. In vitro selection from protein and peptide libraries. Trends Biotechnol. 12:1994;173-184.
54. Glaser SM, Yelton DE, Huse WD. Antibody engineering by codon-based mutagenesis in a filamentous phage system. J Immunol. 149:1992;3903-3913.
55. Virnekas B, Ge L, Pluckthun A, Schneider KC, Wellnhofer G, Moroney SE. Trinucleotide phosphoramidites: ideal reagents for the synthesis of mixed oligonucleotides for random mutagenesis. Nucleic Acids Res. 22:1994;5600-5607.
56. Balint RF, Larrick JW. Antibody engineering by parsimonious mutagenesis. Gene. 137:1993;109-118.
57. Schier R, Balint RF, McCall A, Apell G, Larrick JW, Marks JD. Identification of functional and structural amino-acid residues by parsimonious mutagenesis. Gene. 169:1996;147-155.
58. Hawkins RE, Russell SJ, Winter G. Selection of phage antibodies by binding affinity. Mimicking affinity maturation. J Mol Biol. 226:1992;889-896.
59. Low NM, Holliger PH, Winter G. Mimicking somatic hypermutation: affinity maturation of antibodies displayed on bacteriophage using a bacterial mutator strain. of special interest J Mol Biol. 260:1996;359-368 In a process that closely mimics the somatic hypermutation in B-cells, an anti-hapten antibody was affinity matured 100-fold by propagating phage in a mutator strain (E. coli mutD5) between selection.
60. Schier R, Marks JD. Efficient in vitro affinity maturation of phage antibodies using BIAcore guided selections. Hum Antibodies Hybridomas. 7:1996;97-105.
61. Engberg J, Andersen PS, Nielsen LK, Dziegiel M, Johansen LK, Albrechtsen B. Phage-display libraries of murine and human antibody Fab fragments. Mol Biotechnol. 6:1996;287-310.
62. Parsons HL, Earnshaw JC, Wilton J, Johnson KS, Schueler PA, Mahoney W, McCafferty J. Directing phage selections towards specific epitopes. Protein Eng. 9:1996;1043-1049.
63. Osbourn JK, Derbyshire E, Vaughan T, Field A, Johnson K. Pathfinder selection: in situ isolation of novel antibodies. of outstanding interest Immunotechnology. 1998; A technique using a ligand or antibody-peroxidase conjugate to direct the deposition of biotin-tyramine free radicals within a very local area. Phage antibodies binding close by will be biotinylated and can be retrieved on streptavidin magnetic beads.
64. Schier R, Bye J, Apell G, McCall A, Adams GP, Malmqvist M, Weiner LM, Marks JD. Isolation of high-affinity monomeric human anti-c-erbB-2 single chain Fv using affinity-driven selection. J Mol Biol. 255:1996;28-43.